- امروز : یکشنبه, ۲۷ آبان , ۱۴۰۳
- برابر با : Sunday - 17 November - 2024
اخبار ویژه
Silent Damage First: Alzheimer’s Disease Could Have Two Phases
Sports Concussion Outcomes Can Be Made Worse By Depression
Dad’s Use of Diabetes Med Metformin Won’t Raise Birth Defect Risk
Fitness, Activity Boosts Kids’ Mental Health, Too
Exercise in Pregnancy Might Lower Baby’s Odds for Asthma Later
Some IUDs May Raise The Odds for Breast Cancer, But Overall Risk Remains Low
Music Might Speed Your Recovery From Surgery
A Cancer Diagnosis Takes Devastating Toll on Family Finances
Wegovy (semaglutide)
Experimental GLP-1 Med Might Be Breakthrough Against Fatty Liver Disease
An experimental 'supercharged' form of popular GLP-1 weight-loss meds could help ease fatty liver disease, a new trial suggests.
Wegovy, Ozempic May Help Curb Alcohol Dependence
Could the blockbuster GLP-1 meds like Wegovy and Ozempic have a role to play in helping people cut down on problem drinking? A new study suggests so.
Could New Weight-Loss Drugs Be Changing Women’s Taste for Sweets?
Ozempic and Wegovy appear to improve people’s sensitivity to tastes, potentially lowering their desire for sweets, a new study suggests.
Ozempic Lowers Odds for Death, Illness in People With Kidney Disease and Type 2 Diabetes
Ozempic provides a wide variety of health benefits for people with kidney disease and type 2 diabetes, a major clinical trial has found.
Use of GLP-1 Meds Have Risen 7-Fold Among Young Americans
The number of American teens and young adults who've been prescribed one of the new GLP-1 weight-loss drugs soared nearly seven-fold between 2020 and 2023, a new report finds.
‘Hungry Gut’ Gene Test Shows Who’ll Benefit Most From Wegovy
You've watched others shed pounds in a matter of weeks after taking one of the new blockbuster weight-loss drugs, so you decide to try one of the medications yourself, only to discover the needle on your bathroom scale barely budges.
Stomach Paralysis Risk May Rise in People Taking Ozempic and Similar Drugs
New, real-world research confirms that the blockbuster weight-loss drugs that millions of Americans have been taking to shed pounds can trigger stomach paralysis in some patients.
